Invention Grant
- Patent Title: Injection paradigm for administration of botulinum toxins
- Patent Title (中): 用于给予肉毒杆菌毒素的注射模式
-
Application No.: US13863512Application Date: 2013-04-16
-
Publication No.: US08968747B2Publication Date: 2015-03-03
- Inventor: Catherine C. Turkel , Sheena K. Aurora , Mitchell F. Brin
- Applicant: Allergan, Inc.
- Applicant Address: US CA Irvine
- Assignee: Allergan, Inc.
- Current Assignee: Allergan, Inc.
- Current Assignee Address: US CA Irvine
- Agent Brigitte C. Phan; Ted A. Chan; Debra Condino
- Main IPC: A61K39/08
- IPC: A61K39/08 ; A61P25/00 ; C07K14/33 ; A61K38/48 ; A61K9/00
Abstract:
Disorders such as headaches can be treated by administration of a botulinum toxin to a patient suffering therefrom, such as a migraine headache. A combined a fixed site/fixed dose and an optional follow the pain variable dosage and injection site paradigm is disclosed for optimizing clinical effectiveness of botulinum toxin administration for patients suffering headache, particularly chronic migraine.
Public/Granted literature
- US20130224180A1 INJECTION PARADIGM FOR ADMINISTRATION OF BOTULINUM TOXINS Public/Granted day:2013-08-29
Information query
